# Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients

> **NCT02010931** · — · COMPLETED · sponsor: **Amgen** · enrollment: 310 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02010931
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-03
- **Final completion:** 2014-06
- **Target enrollment:** 310 (ACTUAL)
- **Last updated:** 2022-09-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02010931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02010931, "Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02010931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*